Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
5,522,709
-
Share change
-
-2,107,691
-
Total reported value
-
$9,719,000
-
Price per share
-
$1.76
-
Number of holders
-
36
-
Value change
-
-$2,410,699
-
Number of buys
-
19
-
Number of sells
-
10
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q3 2016
As of 30 Sep 2016,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,522,709 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, Connor, Clark & Lunn Investment Management Ltd., Ancora Advisors, LLC, Iguana Healthcare Management, LLC, DEUTSCHE BANK AG\, WASATCH ADVISORS INC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.